RE:RE:TIME IS RIGHT FOR DCM Hardly a surprise.
Over the last four quarters, DCM has paid out $8.5 million in cash for head count reductions.
That will show up as cost reductions this quarter and each quarter from now.
$2 million in extra cash from reduced interest payments in 2021 and another $2 .million in 2022.
Then add to this, increased operating cash flows from gains in gross margin increases from product mixes, and other accrued gains from nearly $ 7 million in additional cost compression measures taken over the past 5 quarters.
Plus extracting additional cash from reducing another portion of the $20 million in unbilled revenues .
By exit 2022, DCM will be a cash cow extraordinaire..